Hemofi lia A grave con inhibidor: manejo clínico.
The treatment of haemophilia is based on the administration of the defi cient clotting factor (FVIII for haemophilia A and FIX for haemophilia B). One of the main complications is that the administration of factor concentrates can trigger production of inhibitory antibodies targeting the exogenous F...
| Publicado en: | Farmacéutico Hospitales Vol. 225; pp. 59 - 63 |
|---|---|
| Autores principales: | , |
| Formato: | Artículo |
| Publicado: |
Ediciones Mayo
may2023
|
| Acceso en línea: | Ver este registro en EBSCOhost |